We scored every tracked programme on what it publishes before you pay. The results are worse than the marketing suggests.
Across the priced programs we track, only four identify the dispensing pharmacy or a named prescriber before purchase. The rest describe a category — 'a licensed 503A partner' — or say nothing.
That single disclosure is the one that lets a patient check a public state board register before injecting something weekly. It costs a programme nothing to publish and most do not.
Our disclosure score measures publication, not care quality, and the two are not the same. A programme can name six pharmacies and ship late. What naming buys is the ability to verify.
The scoring formula, its seven inputs and every programme's result are published in the open dataset so the number can be recomputed rather than trusted.
Sources
- Our disclosure scoring, computed from the published dataset — source
Dated 2026-08-05. If this item is out of date or wrong, tell us through contact and the change is logged in corrections.
Primary sources
Clinical, dosing and regulatory statements on this page rest on the documents below. Links go to the publisher, not to a summary of it. Prices are not sourced here — they carry a verification date instead, and the reason is set out in the source ledger.
- ZEPBOUND (tirzepatide) full prescribing information — DailyMed, US National Library of Medicine. Dose ladder, contraindications, warnings, storage.
- FDA’s concerns with unapproved GLP-1 drugs used for weight loss — US Food and Drug Administration. Compounded GLP-1 risks, API import alert, cold-chain complaints.
- FD&C Act provisions that apply to human drug compounding — US Food and Drug Administration. Why a compounded preparation is lawful without being FDA-approved.
- Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1) — N Engl J Med 2022;387:205-216. Registration NCT04184622. The weight-reduction and adverse-event figures used across this site.
- The full source ledger — every primary source, what it supports, the date we read it, and the claims we deliberately do not source.